Page last updated: 2024-11-04

sevoflurane and Cardiac Diseases

sevoflurane has been researched along with Cardiac Diseases in 22 studies

Sevoflurane: A non-explosive inhalation anesthetic used in the induction and maintenance of general anesthesia. It does not cause respiratory irritation and may also prevent PLATELET AGGREGATION.
sevoflurane : An ether compound having fluoromethyl and 1,1,1,3,3,3-hexafluoroisopropyl as the two alkyl groups.

Research Excerpts

ExcerptRelevanceReference
"Sevoflurane is associated with less tachycardia and coronary vasodilation than isoflurane and thus might be associated with less myocardial ischemia."9.08Myocardial ischemia and adverse cardiac outcomes in cardiac patients undergoing noncardiac surgery with sevoflurane and isoflurane. Sevoflurane Ischemia Study Group. ( Ebert, TJ; Kharasch, ED; Muzi, M; Rooke, GA; Shroff, A, 1997)
"A randomised controlled study in Caen University Hospital Centre, investigated whether the clinical cardio protective effects of administration sevoflurane before cardiopulmonary bypass during coronary artery bypass graft surgery (CABG) could translate into protected atrial trabeculae contractility against hypoxia-reoxygenation in vitro."5.27Sevoflurane-induced cardioprotection in coronary artery bypass graft surgery: Randomised trial with clinical and ex-vivo endpoints. ( Gérard, JL; Hanouz, JL; Lemoine, S; Zhu, L, 2018)
"To compare the safety of sevoflurane anesthesia with laryngeal mask and tracheal intubation in cesarean section in women with heart disease."5.27[Application of sevoflurane and laryngeal mask in cesarean section in women with heart disease]. ( Ma, J; Wang, S; Wang, ZP; Wei, JF; Xu, JD; Yu, LN, 2018)
"Sevoflurane is associated with less tachycardia and coronary vasodilation than isoflurane and thus might be associated with less myocardial ischemia."5.08Myocardial ischemia and adverse cardiac outcomes in cardiac patients undergoing noncardiac surgery with sevoflurane and isoflurane. Sevoflurane Ischemia Study Group. ( Ebert, TJ; Kharasch, ED; Muzi, M; Rooke, GA; Shroff, A, 1997)
"Sevoflurane, a widely used inhalation anesthetic, has been shown to be cardioprotective in individuals with sepsis and myocardial dysfunction."4.12Molecular Mechanism of Sevoflurane Preconditioning Based on Whole-transcriptome Sequencing of Lipopolysaccharide-induced Cardiac Dysfunction in Mice. ( Li, H; Li, J; Li, S; Li, Y; Xie, J, 2022)
"Sevoflurane may inhibit platelet activation, raising the possibility that administering it during CPB may reduce blood loss."2.82Low-Dose Sevoflurane May Reduce Blood Loss and Need for Blood Products After Cardiac Surgery: A Prospective, Randomized Pilot Study. ( Chen, H; Du, L; Li, J; Liu, T; Luo, M; Qin, Z; Tan, Z; Xiong, J; Zhou, J; Zhou, L, 2016)

Research

Studies (22)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (4.55)18.2507
2000's8 (36.36)29.6817
2010's12 (54.55)24.3611
2020's1 (4.55)2.80

Authors

AuthorsStudies
Xie, J1
Li, H1
Li, S1
Li, J2
Li, Y1
Lemoine, S1
Zhu, L1
Gérard, JL1
Hanouz, JL1
Wang, ZP1
Ma, J1
Wang, S1
Yu, LN1
Wei, JF1
Xu, JD1
Zhou, HM1
Ling, XY1
Ni, YJ1
Wu, C1
Zhu, ZP1
Banchs, R1
Lerman, J1
Wald, SH1
Bonvini, JM1
Beck-Schimmer, B1
Kuhn, SJ1
Graber, SM1
Neff, TA1
Schläpfer, M1
Li, F1
Yuan, Y1
Yu, QB1
Li, HM1
Li, LL1
Wang, SY1
Wu, YB1
Tan, Z1
Zhou, L1
Qin, Z1
Luo, M1
Chen, H1
Xiong, J1
Liu, T1
Du, L1
Zhou, J1
Conghai, F1
Fengchao, Z1
Chengjing, S1
Cheng, W1
Yunji, W1
Xiaobo, L1
Wu, Y1
Wang, J2
Yu, X1
Li, D1
Han, X1
Fan, L1
Bouwman, RA2
Vreden, MJ1
Hamdani, N1
Wassenaar, LE1
Smeding, L1
Loer, SA1
Stienen, GJ1
Lamberts, RR1
Zheng, H1
Chen, CL1
Lu, W1
Zhang, YQ1
Julier, K2
da Silva, R1
Garcia, C2
Bestmann, L3
Frascarolo, P1
Zollinger, A3
Chassot, PG1
Schmid, ER1
Turina, MI1
von Segesser, LK2
Pasch, T2
Spahn, DR2
Zaugg, M3
Müllenheim, J1
Ebel, D1
Bauer, M1
Otto, F1
Heinen, A1
Frässdorf, J1
Preckel, B1
Schlack, W1
de Ruijter, W1
Musters, RJP1
Boer, C2
Stienen, GJM1
Simonides, WS1
de Lange, JJ2
Musters, RJ1
van Beek-Harmsen, BJ1
De Hert, SG1
Van der Linden, PJ1
Cromheecke, S1
Meeus, R1
Nelis, A1
Van Reeth, V1
ten Broecke, PW1
De Blier, IG1
Stockman, BA1
Rodrigus, IE1
Djalali, AG1
Sadovnikoff, N1
Lucchinetti, E1
Hofer, C1
Hersberger, M1
Feng, J1
Zhu, M1
Furrer, L1
Schaub, MC1
Tavakoli, R1
Genoni, M1
Ebert, TJ1
Kharasch, ED1
Rooke, GA1
Shroff, A1
Muzi, M1

Clinical Trials (3)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Comparison Between the Effect of Target-controlled Infusion of Propofol and Sevoflurane as Maintenance of Anesthesia to Intraoperative Hemodynamic Profile of Renal Transplant Recipient[NCT03214653]23 participants (Actual)Interventional2017-07-01Completed
A Comparison of Myocardial Protection Using Preconditioning With Sevoflurane Against High Thoracic Epidural Analgesia for CABG Surgery[NCT00244283]Phase 4150 participants Interventional2006-01-31Not yet recruiting
Optimierung Der Kardioprotektion Durch Inhalative Anästhetika Eine Untersuchung Bei Patienten Mit Diabetes Mellitus während Off-pump Herzchirurgie[NCT02407626]2 participants (Actual)Interventional2015-09-30Terminated (stopped due to Very low patient recruitment, changed insurance requirements)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

2 reviews available for sevoflurane and Cardiac Diseases

ArticleYear
Meta-analysis of the cardioprotective effect of sevoflurane versus propofol during cardiac surgery.
    BMC anesthesiology, 2015, Sep-24, Volume: 15

    Topics: Anesthetics, Inhalation; Anesthetics, Intravenous; Atrial Fibrillation; Cardiac Output; Cardiac Surg

2015
Sevoflurane downregulates interleukin-6 and interleukin-8 levels in patients after cardiopulmonary bypass surgery: a meta-analysis.
    Genetics and molecular research : GMR, 2015, Dec-29, Volume: 14, Issue:4

    Topics: Anti-Inflammatory Agents; Cardiopulmonary Bypass; Case-Control Studies; Down-Regulation; Heart Disea

2015

Trials

10 trials available for sevoflurane and Cardiac Diseases

ArticleYear
Sevoflurane-induced cardioprotection in coronary artery bypass graft surgery: Randomised trial with clinical and ex-vivo endpoints.
    Anaesthesia, critical care & pain medicine, 2018, Volume: 37, Issue:3

    Topics: Aged; Aged, 80 and over; Anesthetics, Inhalation; Cardiotonic Agents; Coronary Artery Bypass; Female

2018
[Application of sevoflurane and laryngeal mask in cesarean section in women with heart disease].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2018, Feb-20, Volume: 38, Issue:2

    Topics: Anesthesia; Blood Pressure; Cesarean Section; Female; Heart Diseases; Heart Rate; Humans; Infant, Ne

2018
Late Post-Conditioning with Sevoflurane after Cardiac Surgery--Are Surrogate Markers Associated with Clinical Outcome?
    PloS one, 2015, Volume: 10, Issue:7

    Topics: Aged; Anesthetics, Inhalation; Cardiac Surgical Procedures; Female; Follow-Up Studies; Heart Disease

2015
Low-Dose Sevoflurane May Reduce Blood Loss and Need for Blood Products After Cardiac Surgery: A Prospective, Randomized Pilot Study.
    Medicine, 2016, Volume: 95, Issue:17

    Topics: Administration, Inhalation; Adult; Blood Loss, Surgical; Dose-Response Relationship, Drug; Erythrocy

2016
Sevoflurane at 1 MAC provides optimal myocardial protection during off-pump CABG.
    Scandinavian cardiovascular journal : SCJ, 2013, Volume: 47, Issue:3

    Topics: Administration, Inhalation; Adult; Aged; Analysis of Variance; Anesthetics, Inhalation; Biomarkers;

2013
Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebo-controlled, multicenter study.
    Anesthesiology, 2003, Volume: 98, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Inhalation; Anesthetics, Inhalation; Biomarkers; Coronar

2003
Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebo-controlled, multicenter study.
    Anesthesiology, 2003, Volume: 98, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Inhalation; Anesthetics, Inhalation; Biomarkers; Coronar

2003
Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebo-controlled, multicenter study.
    Anesthesiology, 2003, Volume: 98, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Inhalation; Anesthetics, Inhalation; Biomarkers; Coronar

2003
Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebo-controlled, multicenter study.
    Anesthesiology, 2003, Volume: 98, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Inhalation; Anesthetics, Inhalation; Biomarkers; Coronar

2003
Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration.
    Anesthesiology, 2004, Volume: 101, Issue:2

    Topics: Aged; Anesthesia, Inhalation; Anesthesia, Intravenous; Anesthetics, Inhalation; Anesthetics, Intrave

2004
Preconditioning with sevoflurane decreases PECAM-1 expression and improves one-year cardiovascular outcome in coronary artery bypass graft surgery.
    British journal of anaesthesia, 2005, Volume: 94, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anesthetics, Inhalation; Cardiotonic Agents; Coronary Artery Bypass;

2005
Gene regulatory control of myocardial energy metabolism predicts postoperative cardiac function in patients undergoing off-pump coronary artery bypass graft surgery: inhalational versus intravenous anesthetics.
    Anesthesiology, 2007, Volume: 106, Issue:3

    Topics: Aged; Aged, 80 and over; Anesthetics, Inhalation; Anesthetics, Intravenous; Biomarkers; Coronary Art

2007
Myocardial ischemia and adverse cardiac outcomes in cardiac patients undergoing noncardiac surgery with sevoflurane and isoflurane. Sevoflurane Ischemia Study Group.
    Anesthesia and analgesia, 1997, Volume: 85, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Anesthetics, Inhalation; Coronary Disease; Ethers; Female; Heart Dis

1997

Other Studies

10 other studies available for sevoflurane and Cardiac Diseases

ArticleYear
Molecular Mechanism of Sevoflurane Preconditioning Based on Whole-transcriptome Sequencing of Lipopolysaccharide-induced Cardiac Dysfunction in Mice.
    Journal of cardiovascular pharmacology, 2022, 06-01, Volume: 79, Issue:6

    Topics: Animals; Heart Diseases; Lipopolysaccharides; Mice; MicroRNAs; Mitogen-Activated Protein Kinases; Ne

2022
Pre-cardiopulmonary bypass administration of dexmedetomidine decreases cardiac troponin I level following cardiac surgery with sevoflurane postconditioning.
    The Journal of international medical research, 2019, Volume: 47, Issue:8

    Topics: Analgesics, Non-Narcotic; Anesthetics, Inhalation; Cardiopulmonary Bypass; Dexmedetomidine; Female;

2019
The use of nitrous oxide as an adjuvant for inhalation inductions with sevoflurane: a pro-con debate.
    Paediatric anaesthesia, 2013, Volume: 23, Issue:6

    Topics: Adolescent; Anesthetics, Inhalation; Apoptosis; Child; Child, Preschool; Drug Interactions; Environm

2013
The Optimum Level of Sevoflurane in Pediatric Echocardiography.
    Cell biochemistry and biophysics, 2015, Volume: 73, Issue:2

    Topics: Anesthetics, Inhalation; Blood Pressure; Child, Preschool; Echocardiography; Female; Heart Diseases;

2015
Sevoflurane ameliorates doxorubicin-induced myocardial injury by affecting the phosphorylation states of proteins in PI3K/Akt/mTOR signaling pathway.
    Cardiology journal, 2017, Volume: 24, Issue:4

    Topics: Animals; Apoptosis; Cardiotoxicity; Cell Line; Creatine Kinase, MB Form; Cytoprotection; Disease Mod

2017
Effect of bupivacaine on sevoflurane-induced preconditioning in isolated rat hearts.
    European journal of pharmacology, 2010, Nov-25, Volume: 647, Issue:1-3

    Topics: Anesthetics, Inhalation; Anesthetics, Local; Animals; Bupivacaine; Heart; Heart Diseases; In Vitro T

2010
Sevoflurane confers additional cardioprotection after ischemic late preconditioning in rabbits.
    Anesthesiology, 2003, Volume: 99, Issue:3

    Topics: Anesthetics, Inhalation; Animals; ATP-Binding Cassette Transporters; Blood Pressure; Coronary Vessel

2003
The cardioprotective effect of sevoflurane depends on protein kinase C activation, opening of mitochondrial K(+)(ATP) channels, and the production of reactive oxygen species.
    Anesthesia and analgesia, 2003, Volume: 97, Issue:5

    Topics: Anesthetics, Inhalation; Animals; ATP-Binding Cassette Transporters; Enzyme Activation; Enzyme Inhib

2003
Reactive oxygen species precede protein kinase C-delta activation independent of adenosine triphosphate-sensitive mitochondrial channel opening in sevoflurane-induced cardioprotection.
    Anesthesiology, 2004, Volume: 100, Issue:3

    Topics: Anesthetics, Inhalation; Animals; Enzyme Activation; Heart; Heart Diseases; Image Processing, Comput

2004
Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration.
    Anesthesiology, 2005, Volume: 102, Issue:3

    Topics: Anesthetics, Inhalation; Cardiopulmonary Bypass; Heart Diseases; Humans; Methyl Ethers; Protective A

2005